BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 11042028)

  • 1. Distinct phenotypic expression associated with a new hyperunstable alpha globin variant (Hb heraklion, alpha1cd37(C2)Pro>0): comparison to other alpha-thalassemic hemoglobinopathies.
    Traeger-Synodinos J; Papassotiriou I; Metaxotou-Mavrommati A; Vrettou C; Stamoulakatou A; Kanavakis E
    Blood Cells Mol Dis; 2000 Aug; 26(4):276-84. PubMed ID: 11042028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype.
    Murru S; Poddie D; Sciarratta GV; Agosti S; Baffico M; Melevendi C; Pirastu M; Cao A
    Hum Mutat; 1992; 1(2):124-8. PubMed ID: 1301199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalassemic hemoglobinopathies.
    Steinberg MH; Adams JG
    Am J Pathol; 1983 Dec; 113(3):396-409. PubMed ID: 6359893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low output hemoglobins which produce the phenotype of thalassemia.
    Adams JG; Steinberg MH
    Prog Clin Biol Res; 1981; 55():81-98. PubMed ID: 6895257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of alpha-thalassemia in Thailand.
    Winichagoon P; Fucharoen S; Wasi P
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():7-13. PubMed ID: 1298997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of hemoglobin H disease by sickle trait.
    Matthay KK; Mentzer WC; Dozy AM; Kan YW; Bainton DF
    J Clin Invest; 1979 Oct; 64(4):1024-32. PubMed ID: 479366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoglobin Sabine [beta 91 (F7) Leu-->Pro]: occurrence in a Sardinian individual with hemolytic anemia and inclusion bodies.
    Gasperini D; Galanello R; Melis MA; Iannelli S; Giordano P; Bernini LF; Cao A
    Haematologica; 1992; 77(5):381-3. PubMed ID: 1336469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoglobin Cagliari (beta 60 [E4] Val----Glu): a novel unstable thalassemic hemoglobinopathy.
    Podda A; Galanello R; Maccioni L; Melis MA; Rosatelli C; Perseu L; Cao A
    Blood; 1991 Jan; 77(2):371-5. PubMed ID: 1985702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different hematologic phenotypes are associated with the leftward (-alpha 4.2) and rightward (-alpha 3.7) alpha+-thalassemia deletions.
    Bowden DK; Hill AV; Higgs DR; Oppenheimer SJ; Weatherall DJ; Clegg JB
    J Clin Invest; 1987 Jan; 79(1):39-43. PubMed ID: 3793931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-globin gene deletions associated with Hb J Tongariki.
    Bowden DK; Pressley L; Higgs DR; Clegg JB; Weatherall DJ
    Br J Haematol; 1982 Jun; 51(2):243-9. PubMed ID: 6979350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemoglobinopathies in Japan].
    Miyaji T
    Rinsho Ketsueki; 1989 Aug; 30(8):1147-56. PubMed ID: 2601023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin Indianapolis (beta 112[G14] arginine). An unstable beta-chain variant producing the phenotype of severe beta-thalassemia.
    Adams JG; Boxer LA; Baehner RL; Forget BG; Tsistrakis GA; Steinberg MH
    J Clin Invest; 1979 May; 63(5):931-8. PubMed ID: 447835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-, delta beta-thalassemia and Hb lepore among Yugoslav, Bulgarian, Turkish and Albanian.
    Efremov GD
    Haematologica; 1990; 75 Suppl 5():31-41. PubMed ID: 2086380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassemias in Sardinia: molecular pathology, phenotype-genotype correlation, and prevention.
    Cao A; Rosatelli C; Pirastu M; Galanello R
    Am J Pediatr Hematol Oncol; 1991; 13(2):179-88. PubMed ID: 2069229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygosity for the IVS-I-5 (G-->C) mutation with a G-->A change at codon 18 (Val-->Met; Hb Baden) in cis and a T-->G mutation at codon 126 (Val-->Gly; Hb Dhonburi) in trans resulting in a thalassemia intermedia.
    Divoky V; Bissé E; Wilson JB; Gu LH; Wieland H; Heinrichs I; Prior JF; Huisman TH
    Biochim Biophys Acta; 1992 Dec; 1180(2):173-9. PubMed ID: 1463768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid molecular characterization of mutations leading to unstable hemoglobin beta-chain variants.
    Girodon E; Ghanem N; Vidaud M; Riou J; Martin J; Galactéros F; Goossens M
    Ann Hematol; 1992 Oct; 65(4):188-92. PubMed ID: 1420507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of deletion and triple alpha-globin gene haplotypes in the Montreal beta-thalassemia screening program: implications for genetic medicine.
    Akerman BR; Fujiwara TM; Lancaster GA; Morgan K; Scriver CR
    Am J Med Genet; 1990 May; 36(1):76-84. PubMed ID: 2333910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current views of thalassemia intermedia].
    Longinotti M; Dore F; Oggiano L; Pardini S; Pistidda P; Guiso L; Frogheri L; Bonfigli S; Murineddu M; Rimini E
    Recenti Prog Med; 1992 Apr; 83(4):233-40. PubMed ID: 1626119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemoglobin Boumerdès alpha 2(37) (C2) Pro----Arg beta 2: a new variant of the alpha chain associated with hemoglobin S in an Algerian family].
    Dahmane-Arbane M; Blouquit Y; Arous N; Bardakdjian J; Benamani M; Riou J; Benabadji M; Rosa J; Galacteros F
    Nouv Rev Fr Hematol (1978); 1987; 29(5):317-20. PubMed ID: 3438164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of a program for atypical familial microcytosis. Molecular basis of alpha-thalassemia].
    Villegas Martínez A
    Sangre (Barc); 1990 Aug; 35(4):277-88. PubMed ID: 2274839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.